← All Sponsors
SPONSOR

Cerium Pharmaceuticals, Inc.

Total Trials
1
Recruiting
1
Phases
Phase 3
Conditions studied: Primary Membranous Nephropathy
NCT05696613 Phase 3
Recruiting

A Study of SNP-ACTH (1-39) Gel in Patients With Primary Membranous Nephropathy

Primary Membranous Nephropathy
United States, Canada, India View Trial →